{
    "abstract": "An International Standard to harmonise results from RSV subtype A neutralisation assays was generated and established by the World Health Organization in 2018. Here we report on a study to expand the use of that standard to include neutralisation assays using human sera against RSV subtype B and to test its ability to harmonise neutralisation titres from neutralisation assays including complement. The study included 11 laboratories from 6 countries. All participants used their own in-house virus neutralisation assay and their own virus stocks. The study samples comprised the current International Standard (16/284) and its potential replacement (16/322), individual sera from naturally infected humans, a monoclonal antibody to RSV (palivizumab) and samples from the BEI Resources panel of human antiserum and immune globulin to RSV. Of the 11 laboratories that took part in the study, 5 returned data from neutralisation assays with and without the inclusion of serum complement. The study showed that inter-laboratory variability in neutralisation titres was significantly reduced when values were expressed relative to 16/284 or 16/322. Complement did not affect the ability of the International Standard to decrease inter-laboratory variability as the standard was able to reduce the differences between titres from assays with and without complement. Based on these results, we will recommend to the WHO Expert Committee on Biological Standardisation (ECBS) that 16/284 and 16/322 be expanded in their use to include neutralisation assays against RSV/B.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Ting",
                    "initial": "T.",
                    "last": "Shi"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "McAllister"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Eric A.F.",
                    "initial": "E.A.F.",
                    "last": "Simoes"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Bradford D.",
                    "initial": "B.D.",
                    "last": "Gessner"
                },
                {
                    "first": "Fernando P.",
                    "initial": "F.P.",
                    "last": "Polack"
                },
                {
                    "first": "Evelyn",
                    "initial": "E.",
                    "last": "Balsells"
                },
                {
                    "first": "Sozinho",
                    "initial": "S.",
                    "last": "Acacio"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Aguayo"
                },
                {
                    "first": "Issifou",
                    "initial": "I.",
                    "last": "Alassani"
                },
                {
                    "first": "Asad",
                    "initial": "A.",
                    "last": "Ali"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Shally",
                    "initial": "S.",
                    "last": "Awasthi"
                },
                {
                    "first": "Juliet O.",
                    "initial": "J.O.",
                    "last": "Awori"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Azziz-Baumgartner"
                },
                {
                    "first": "Henry C.",
                    "initial": "H.C.",
                    "last": "Baggett"
                },
                {
                    "first": "Vicky L.",
                    "initial": "V.L.",
                    "last": "Baillie"
                },
                {
                    "first": "Angel",
                    "initial": "A.",
                    "last": "Balmaseda"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Barahona"
                },
                {
                    "first": "Sudha",
                    "initial": "S.",
                    "last": "Basnet"
                },
                {
                    "first": "Quique",
                    "initial": "Q.",
                    "last": "Bassat"
                },
                {
                    "first": "Wilma",
                    "initial": "W.",
                    "last": "Basualdo"
                },
                {
                    "first": "Godfrey",
                    "initial": "G.",
                    "last": "Bigogo"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Bont"
                },
                {
                    "first": "Robert F.",
                    "initial": "R.F.",
                    "last": "Breiman"
                },
                {
                    "first": "W. Abdullah",
                    "initial": "W.A.",
                    "last": "Brooks"
                },
                {
                    "first": "Shobha",
                    "initial": "S.",
                    "last": "Broor"
                },
                {
                    "first": "Nigel",
                    "initial": "N.",
                    "last": "Bruce"
                },
                {
                    "first": "Dana",
                    "initial": "D.",
                    "last": "Bruden"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Buchy"
                },
                {
                    "first": "Stuart",
                    "initial": "S.",
                    "last": "Campbell"
                },
                {
                    "first": "Phyllis",
                    "initial": "P.",
                    "last": "Carosone-Link"
                },
                {
                    "first": "Mandeep",
                    "initial": "M.",
                    "last": "Chadha"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Chipeta"
                },
                {
                    "first": "Monidarin",
                    "initial": "M.",
                    "last": "Chou"
                },
                {
                    "first": "Wilfrido",
                    "initial": "W.",
                    "last": "Clara"
                },
                {
                    "first": "Cheryl",
                    "initial": "C.",
                    "last": "Cohen"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "de Cuellar"
                },
                {
                    "first": "Duc Anh",
                    "initial": "D.A.",
                    "last": "Dang"
                },
                {
                    "first": "Budragchaagiin",
                    "initial": "B.",
                    "last": "Dash-yandag"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Deloria-Knoll"
                },
                {
                    "first": "Mukesh",
                    "initial": "M.",
                    "last": "Dherani"
                },
                {
                    "first": "Tekchheng",
                    "initial": "T.",
                    "last": "Eap"
                },
                {
                    "first": "Bernard E.",
                    "initial": "B.E.",
                    "last": "Ebruke"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Echavarria"
                },
                {
                    "first": "Carla Cec\u00edlia",
                    "initial": "C.C.",
                    "last": "de Freitas L\u00e1zaro Emediato"
                },
                {
                    "first": "Rodrigo A.",
                    "initial": "R.A.",
                    "last": "Fasce"
                },
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Feikin"
                },
                {
                    "first": "Luzhao",
                    "initial": "L.",
                    "last": "Feng"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Gentile"
                },
                {
                    "first": "Aubree",
                    "initial": "A.",
                    "last": "Gordon"
                },
                {
                    "first": "Doli",
                    "initial": "D.",
                    "last": "Goswami"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Goyet"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Groome"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Halasa"
                },
                {
                    "first": "Siddhivinayak",
                    "initial": "S.",
                    "last": "Hirve"
                },
                {
                    "first": "Nusrat",
                    "initial": "N.",
                    "last": "Homaira"
                },
                {
                    "first": "Stephen R.C.",
                    "initial": "S.R.C.",
                    "last": "Howie"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Jara"
                },
                {
                    "first": "Imane",
                    "initial": "I.",
                    "last": "Jroundi"
                },
                {
                    "first": "Cissy B.",
                    "initial": "C.B.",
                    "last": "Kartasasmita"
                },
                {
                    "first": "Najwa",
                    "initial": "N.",
                    "last": "Khuri-Bulos"
                },
                {
                    "first": "Karen L.",
                    "initial": "K.L.",
                    "last": "Kotloff"
                },
                {
                    "first": "Anand",
                    "initial": "A.",
                    "last": "Krishnan"
                },
                {
                    "first": "Romina",
                    "initial": "R.",
                    "last": "Libster"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Lopez"
                },
                {
                    "first": "Marilla G.",
                    "initial": "M.G.",
                    "last": "Lucero"
                },
                {
                    "first": "Florencia",
                    "initial": "F.",
                    "last": "Lucion"
                },
                {
                    "first": "Socorro P.",
                    "initial": "S.P.",
                    "last": "Lupisan"
                },
                {
                    "first": "Debora N.",
                    "initial": "D.N.",
                    "last": "Marcone"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "McCracken"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Mejia"
                },
                {
                    "first": "Jennifer C.",
                    "initial": "J.C.",
                    "last": "Moisi"
                },
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Montgomery"
                },
                {
                    "first": "David P.",
                    "initial": "D.P.",
                    "last": "Moore"
                },
                {
                    "first": "Cinta",
                    "initial": "C.",
                    "last": "Moraleda"
                },
                {
                    "first": "Jocelyn",
                    "initial": "J.",
                    "last": "Moyes"
                },
                {
                    "first": "Patrick",
                    "initial": "P.",
                    "last": "Munywoki"
                },
                {
                    "first": "Kuswandewi",
                    "initial": "K.",
                    "last": "Mutyara"
                },
                {
                    "first": "Mark P.",
                    "initial": "M.P.",
                    "last": "Nicol"
                },
                {
                    "first": "D. James",
                    "initial": "D.J.",
                    "last": "Nokes"
                },
                {
                    "first": "Pagbajabyn",
                    "initial": "P.",
                    "last": "Nymadawa"
                },
                {
                    "first": "Maria Tereza",
                    "initial": "M.T.",
                    "last": "da Costa Oliveira"
                },
                {
                    "first": "Histoshi",
                    "initial": "H.",
                    "last": "Oshitani"
                },
                {
                    "first": "Nitin",
                    "initial": "N.",
                    "last": "Pandey"
                },
                {
                    "first": "Gl\u00e1ucia",
                    "initial": "G.",
                    "last": "Paranhos-Baccal\u00e0"
                },
                {
                    "first": "Lia N.",
                    "initial": "L.N.",
                    "last": "Phillips"
                },
                {
                    "first": "Valentina Sanchez",
                    "initial": "V.S.",
                    "last": "Picot"
                },
                {
                    "first": "Mustafizur",
                    "initial": "M.",
                    "last": "Rahman"
                },
                {
                    "first": "Mala",
                    "initial": "M.",
                    "last": "Rakoto-Andrianarivelo"
                },
                {
                    "first": "Zeba A.",
                    "initial": "Z.A.",
                    "last": "Rasmussen"
                },
                {
                    "first": "Barbara A.",
                    "initial": "B.A.",
                    "last": "Rath"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Robinson"
                },
                {
                    "first": "Candice",
                    "initial": "C.",
                    "last": "Romero"
                },
                {
                    "first": "Graciela",
                    "initial": "G.",
                    "last": "Russomando"
                },
                {
                    "first": "Vahid",
                    "initial": "V.",
                    "last": "Salimi"
                },
                {
                    "first": "Pongpun",
                    "initial": "P.",
                    "last": "Sawatwong"
                },
                {
                    "first": "Nienke",
                    "initial": "N.",
                    "last": "Scheltema"
                },
                {
                    "first": "Brunhilde",
                    "initial": "B.",
                    "last": "Schweiger"
                },
                {
                    "first": "J. Anthony G.",
                    "initial": "J.A.G.",
                    "last": "Scott"
                },
                {
                    "first": "Phil",
                    "initial": "P.",
                    "last": "Seidenberg"
                },
                {
                    "first": "Kunling",
                    "initial": "K.",
                    "last": "Shen"
                },
                {
                    "first": "Rosalyn",
                    "initial": "R.",
                    "last": "Singleton"
                },
                {
                    "first": "Viviana",
                    "initial": "V.",
                    "last": "Sotomayor"
                },
                {
                    "first": "Tor A.",
                    "initial": "T.A.",
                    "last": "Strand"
                },
                {
                    "first": "Agustinus",
                    "initial": "A.",
                    "last": "Sutanto"
                },
                {
                    "first": "Mariam",
                    "initial": "M.",
                    "last": "Sylla"
                },
                {
                    "first": "Milagritos D.",
                    "initial": "M.D.",
                    "last": "Tapia"
                },
                {
                    "first": "Somsak",
                    "initial": "S.",
                    "last": "Thamthitiwat"
                },
                {
                    "first": "Elizabeth D.",
                    "initial": "E.D.",
                    "last": "Thomas"
                },
                {
                    "first": "Rafal",
                    "initial": "R.",
                    "last": "Tokarz"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Turner"
                },
                {
                    "first": "Marietjie",
                    "initial": "M.",
                    "last": "Venter"
                },
                {
                    "first": "Sunthareeya",
                    "initial": "S.",
                    "last": "Waicharoen"
                },
                {
                    "first": "Jianwei",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Wanitda",
                    "initial": "W.",
                    "last": "Watthanaworawit"
                },
                {
                    "first": "Lay Myint",
                    "initial": "L.M.",
                    "last": "Yoshida"
                },
                {
                    "first": "Hongjie",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Heather J.",
                    "initial": "H.J.",
                    "last": "Zar"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/S0140-6736(17)30938-8",
            "firstpage": "946",
            "issn": "01406736",
            "lastpage": "958",
            "pmid": "28689664",
            "pub_year": 2017,
            "title": "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study",
            "volume": "390"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Ann R.",
                    "initial": "A.R.",
                    "last": "Falsey"
                },
                {
                    "first": "Edward E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                }
            ],
            "doi": "10.1128/CMR.13.3.371-384.2000",
            "firstpage": "371",
            "issn": "08938512",
            "lastpage": "384",
            "pmid": "10885982",
            "pub_year": 2000,
            "title": "Respiratory syncytial virus infection in adults",
            "volume": "13"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Ann D.",
                    "initial": "A.D.",
                    "last": "Colosia"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Yang"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Hillson"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "Mauskopf"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Copley-Merriman"
                },
                {
                    "first": "Vivek",
                    "initial": "V.",
                    "last": "Shinde"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Stoddard"
                }
            ],
            "doi": "10.1371/journal.pone.0182321",
            "issn": "19326203",
            "pmid": "28797053",
            "pub_year": 2017,
            "title": "The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review",
            "volume": "12"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Alexey",
                    "initial": "A.",
                    "last": "Ruzin"
                },
                {
                    "first": "Susan T.",
                    "initial": "S.T.",
                    "last": "Pastula"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Levin-Sparenberg"
                },
                {
                    "first": "Xiaohui",
                    "initial": "X.",
                    "last": "Jiang"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Fryzek"
                },
                {
                    "first": "Andrey",
                    "initial": "A.",
                    "last": "Tovchigrechko"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Lu"
                },
                {
                    "first": "Yanping",
                    "initial": "Y.",
                    "last": "Qi"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Liu"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Yu"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Hackett"
                },
                {
                    "first": "Tonya",
                    "initial": "T.",
                    "last": "Villafana"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Esser"
                }
            ],
            "doi": "10.1371/journal.pone.0200319",
            "issn": "19326203",
            "pmid": "30040837",
            "pub_year": 2018,
            "title": "Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States",
            "volume": "13"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Teresa C.T.",
                    "initial": "T.C.T.",
                    "last": "Peret"
                },
                {
                    "first": "Caroline B.",
                    "initial": "C.B.",
                    "last": "Hall"
                },
                {
                    "first": "Gregory W.",
                    "initial": "G.W.",
                    "last": "Hammond"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Storch"
                },
                {
                    "first": "Wayne M.",
                    "initial": "W.M.",
                    "last": "Sullender"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Tsou"
                },
                {
                    "first": "Larry J.",
                    "initial": "L.J.",
                    "last": "Anderson"
                }
            ],
            "doi": "10.1086/315508",
            "firstpage": "1891",
            "issn": "00221899",
            "lastpage": "1896",
            "pmid": "10837167",
            "pub_year": 2000,
            "title": "Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America",
            "volume": "181"
        },
        "b0030": null,
        "b0035": {
            "authors": [
                {
                    "first": "Kayvon",
                    "initial": "K.",
                    "last": "Modjarrad"
                },
                {
                    "first": "Birgitte",
                    "initial": "B.",
                    "last": "Giersing"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Smith"
                },
                {
                    "first": "Vasee S.",
                    "initial": "V.S.",
                    "last": "Moorthy"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.05.093",
            "firstpage": "190",
            "issn": "0264410X",
            "lastpage": "197",
            "pmid": "26100926",
            "pub_year": 2016,
            "title": "WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015",
            "volume": "34"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Hosken"
                },
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Plikaytis"
                },
                {
                    "first": "Carrie",
                    "initial": "C.",
                    "last": "Trujillo"
                },
                {
                    "first": "Kutub",
                    "initial": "K.",
                    "last": "Mahmood"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Higgins"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.053",
            "firstpage": "3082",
            "issn": "0264410X",
            "lastpage": "3088",
            "pmid": "28476625",
            "pub_year": 2017,
            "title": "A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard",
            "volume": "35"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Jacqueline U.",
                    "initial": "J.U.",
                    "last": "McDonald"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Rigsby"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Dougall"
                },
                {
                    "first": "Othmar G.",
                    "initial": "O.G.",
                    "last": "Engelhardt"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2018.10.087",
            "firstpage": "7641",
            "issn": "0264410X",
            "lastpage": "7649",
            "pmid": "30389194",
            "pub_year": 2018,
            "title": "Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study",
            "volume": "36"
        },
        "b0055": {
            "authors": [
                {
                    "first": "T. N.",
                    "initial": "T.N.",
                    "last": "Kaul"
                },
                {
                    "first": "R. C.",
                    "initial": "R.C.",
                    "last": "Welliver"
                },
                {
                    "first": "P. L.",
                    "initial": "P.L.",
                    "last": "Ogra"
                }
            ],
            "firstpage": "957",
            "issn": "00951137",
            "lastpage": "962",
            "pmid": "7016915",
            "pub_year": 1981,
            "title": "Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus",
            "volume": "13"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Sandra M.",
                    "initial": "S.M.",
                    "last": "Yoder"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Mine R.",
                    "initial": "M.R.",
                    "last": "Ikizler"
                },
                {
                    "first": "Peter F.",
                    "initial": "P.F.",
                    "last": "Wright"
                }
            ],
            "doi": "10.1002/jmv.20046",
            "firstpage": "688",
            "issn": "01466615",
            "lastpage": "694",
            "pmid": "14981775",
            "pub_year": 2004,
            "title": "Role of Complement in Neutralization of Respiratory Syncytial Virus",
            "volume": "72"
        },
        "b0065": null,
        "b0070": {
            "authors": [
                {
                    "first": "Tauno",
                    "initial": "T.",
                    "last": "Metsalu"
                },
                {
                    "first": "Jaak",
                    "initial": "J.",
                    "last": "Vilo"
                }
            ],
            "doi": "10.1093/nar/gkv468",
            "firstpage": "W566",
            "issn": "03051048",
            "lastpage": "W570",
            "pmid": "25969447",
            "pub_year": 2015,
            "title": "ClustVis: A web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap",
            "volume": "43"
        },
        "b0075": null,
        "b0080": null,
        "b0085": {
            "authors": [
                {
                    "first": "Syd",
                    "initial": "S.",
                    "last": "Johnson"
                },
                {
                    "first": "Cynthia",
                    "initial": "C.",
                    "last": "Oliver"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "Val G.",
                    "initial": "V.G.",
                    "last": "Hemming"
                },
                {
                    "first": "David S.",
                    "initial": "D.S.",
                    "last": "Pfarr"
                },
                {
                    "first": "Sheau Chiann",
                    "initial": "S.C.",
                    "last": "Wang"
                },
                {
                    "first": "Melissa",
                    "initial": "M.",
                    "last": "Dormitzcr"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "O'Grady"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Koenig"
                },
                {
                    "first": "James K.",
                    "initial": "J.K.",
                    "last": "Tamura"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Woods"
                },
                {
                    "first": "Geetha",
                    "initial": "G.",
                    "last": "Bansal"
                },
                {
                    "first": "Debra",
                    "initial": "D.",
                    "last": "Couchenour"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Tsao"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Hall"
                },
                {
                    "first": "James F.",
                    "initial": "J.F.",
                    "last": "Young"
                }
            ],
            "doi": "10.1086/514115",
            "firstpage": "1215",
            "issn": "00221899",
            "lastpage": "1224",
            "pmid": "9359721",
            "pub_year": 1997,
            "title": "Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus",
            "volume": "176"
        }
    },
    "body_text": [
        {
            "endOffset": 30219,
            "parents": [],
            "secId": "s0090",
            "sentence": "Based on the results of this study, we recommend to the WHO Expert Committee on Biological Standardisation (ECBS) that 16/284 be expanded in its intended use to include harmonisation of neutralisation titres against RSV/B with an International Unitage of 1000 IU per ampoule and that 16/322 be retained as its potential replacement with an International Unitage of 690 IU per ampoule.",
            "startOffset": 29835,
            "title": "Conclusions"
        },
        {
            "endOffset": 22735,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "With the exception of samples 3 and 14 (palivizumab), expressing the titres as potencies relative to 16/284 reduced inter-laboratory variability, with the Max:Min ratio ranging from 2 to 7, %GCV ranging from 19% to 70%, and the median %GCV being 37% (Fig. 2D, Tables 2 and 3).",
            "startOffset": 22459,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 18921,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Laboratories in the complement group performed the assay with and without the addition of guinea pig complement.",
            "startOffset": 18809,
            "title": "Study plan"
        },
        {
            "endOffset": 16373,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 16372,
                    "startOffset": 16365
                },
                "b0060": {
                    "endOffset": 16372,
                    "startOffset": 16365
                }
            },
            "secId": "s0005",
            "sentence": "Complement has been shown to increase titres in RSV neutralisation assays [11,12].",
            "startOffset": 16291,
            "title": "Introduction"
        },
        {
            "endOffset": 15135,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 15134,
                    "startOffset": 15129
                },
                "b0015": {
                    "endOffset": 15134,
                    "startOffset": 15129
                }
            },
            "secId": "s0005",
            "sentence": "It is also a serious cause for concern for elderly and immunocompromised adults [2,3].",
            "startOffset": 15049,
            "title": "Introduction"
        },
        {
            "endOffset": 20687,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 20686,
                    "startOffset": 20682
                }
            },
            "secId": "s0045",
            "sentence": "To allow for like for like comparisons, ED50 values for these datasets were calculated using CombiStats [16].",
            "startOffset": 20578,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 30399,
            "parents": [],
            "secId": "s0090",
            "sentence": "We recommend that vaccine developers and researchers use the international standard to make results between clinical studies conducted by different laboratories better comparable.",
            "startOffset": 30220,
            "title": "Conclusions"
        },
        {
            "endOffset": 28415,
            "parents": [],
            "secId": "s0085",
            "sentence": "Samples from the BEI Resources panel were included to assess their ability to act as working standards for RSV/B neutralisation assays.",
            "startOffset": 28280,
            "title": "Discussion"
        },
        {
            "endOffset": 19529,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Variability between laboratories was expressed using Geometric Coefficients of Variation (%GCV) i.e. (10 s\u22121) \u00d7 100%, where s is the standard deviation of the log10 ED50s or log10 relative potency estimates.",
            "startOffset": 19322,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29036,
            "parents": [],
            "secId": "s0085",
            "sentence": "Here we show that the titre differences between assays with and without complement are significant but that the use of the standard reduces this difference until the significance disappears (Fig. 5), making these two sets of data effectively comparable.",
            "startOffset": 28783,
            "title": "Discussion"
        },
        {
            "endOffset": 22283,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The Max:Min ratio calculated from the maximum and minimum laboratory GM estimates ranged from 12 to 82 and the %GCV ranged from 145% to 215%, with a median %GCV of 167%.",
            "startOffset": 22114,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 21878,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Where this ratio was greater than 3.5, all results for that sample in that laboratory were excluded from further analysis.",
            "startOffset": 21756,
            "title": "Intra and Inter-Assay variability"
        },
        {
            "endOffset": 27940,
            "parents": [],
            "secId": "s0085",
            "sentence": "While the antibodies in the standard are in human serum, which constitutes a complex mix of proteins, lipids and carbohydrates, the palivizumab samples were reconstituted and diluted in PBS.",
            "startOffset": 27750,
            "title": "Discussion"
        },
        {
            "endOffset": 27749,
            "parents": [],
            "secId": "s0085",
            "sentence": "Another possible explanation could be due to the different nature of the matrix of the standard and of the palivizumab samples.",
            "startOffset": 27622,
            "title": "Discussion"
        },
        {
            "endOffset": 15239,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 15238,
                    "startOffset": 15233
                },
                "b0025": {
                    "endOffset": 15238,
                    "startOffset": 15233
                }
            },
            "secId": "s0005",
            "sentence": "RSV consists of 2 major sub-types, A and B, which co-circulate seasonally and both cause disease [4,5].",
            "startOffset": 15136,
            "title": "Introduction"
        },
        {
            "endOffset": 16158,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 16157,
                    "startOffset": 16153
                }
            },
            "secId": "s0005",
            "sentence": "We previously produced a WHO International Standard which allowed harmonisation of RSV/A neutralisation titres across multiple platforms [10].",
            "startOffset": 16016,
            "title": "Introduction"
        },
        {
            "endOffset": 25787,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "When expressed as IU using either 16/284 or 16/322 as standards, all labs that returned data showed coefficient values of \u22650.8 (Supplementary Table 5).",
            "startOffset": 25636,
            "title": "Complement effects"
        },
        {
            "endOffset": 23842,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "When the results were expressed as potencies relative to all 3 of these samples, a decrease in %GCV was observed, which remained when the results were categorised by the presence or absence of complement (Table 3 and Supplementary Table 4).",
            "startOffset": 23602,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 28782,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 28781,
                    "startOffset": 28777
                }
            },
            "secId": "s0085",
            "sentence": "The use of complement in RSV neutralisation assays leads to increased neutralisation titres [11].",
            "startOffset": 28685,
            "title": "Discussion"
        },
        {
            "endOffset": 25461,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The percentage difference between the titres of the samples when tested with and without complement was calculated; titres expressed as ED50 had a significantly increased percentage difference compared to titres expressed as IU/mL relative to 16/284 (P = 0.0111; Fig. 5B) and 16/322 (P = 0.0354; Fig. 5B).",
            "startOffset": 25156,
            "title": "Complement effects"
        },
        {
            "endOffset": 18808,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "All participants were asked to measure the neutralisation titre of each sample against any RSV/B strain, to reflect real-world assay variability, in 4 independent assay runs, and were given instructions on sample storage and handling.",
            "startOffset": 18574,
            "title": "Study plan"
        },
        {
            "endOffset": 29388,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 29387,
                    "startOffset": 29383
                }
            },
            "secId": "s0085",
            "sentence": "However, in our previous study assessing neutralisation of RSV/A viruses, paediatric sera were tested and the standards were found to behave similarly with paediatric and adult human serum samples [10].",
            "startOffset": 29186,
            "title": "Discussion"
        },
        {
            "endOffset": 26146,
            "parents": [],
            "secId": "s0085",
            "sentence": "There was a high degree of variability across the data generated from the laboratories participating in the collaborative study.",
            "startOffset": 26018,
            "title": "Discussion"
        },
        {
            "endOffset": 21612,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "In the previous collaborative study, assays were excluded from further analysis where the results for the coded duplicate within an assay differed by a factor of >2.5, but this study found no coded duplicates that differed by a factor of >2.5, so no assays were excluded for poor intra-assay variability (Fig. 1A).",
            "startOffset": 21298,
            "title": "Intra and Inter-Assay variability"
        },
        {
            "endOffset": 15540,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 15539,
                    "startOffset": 15536
                }
            },
            "secId": "s0005",
            "sentence": "There is currently no preventative RSV vaccine, but the development of such a vaccine is recognised as a global priority by the World Health Organization (WHO) [7].",
            "startOffset": 15376,
            "title": "Introduction"
        },
        {
            "endOffset": 17435,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 17434,
                    "startOffset": 17430
                }
            },
            "secId": "s0015",
            "sentence": "Briefly, the standards were made by combining six serum samples with a high or medium neutralising titre that had been shown to harmonise RSV neutralisation results when used individually [10].",
            "startOffset": 17242,
            "title": "Production of 16/284 and 16/322"
        },
        {
            "endOffset": 17241,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 17240,
                    "startOffset": 17233
                },
                "b0065": {
                    "endOffset": 17240,
                    "startOffset": 17233
                }
            },
            "secId": "s0015",
            "sentence": "Full details on the production of 16/284 and 16/322 can be found in the report to establish the 1st International Standard for antiserum to RSV [10,13].",
            "startOffset": 17089,
            "title": "Production of 16/284 and 16/322"
        },
        {
            "endOffset": 19241,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Analysis was performed using ED50s reported by the participants or calculated at NIBSC and also using relative potencies i.e. ED50s expressed relative to IS 16/284 or 16/322.",
            "startOffset": 19067,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 16548,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 16512,
                    "startOffset": 16508
                }
            },
            "secId": "s0005",
            "sentence": "While not routinely used by all laboratories, inclusion of complement in neutralisation assays still occurs and in our previous study [10] one laboratory included complement.",
            "startOffset": 16374,
            "title": "Introduction"
        },
        {
            "endOffset": 24446,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The level of agreement between the individual laboratories was assessed with concordance correlation coefficients.",
            "startOffset": 24332,
            "title": "Agreement between individual laboratories"
        },
        {
            "endOffset": 29823,
            "parents": [],
            "secId": "s0085",
            "sentence": "While the standards are useful for human sera, we recommend that a more suitable standard be considered for monoclonal antibodies.",
            "startOffset": 29693,
            "title": "Discussion"
        },
        {
            "endOffset": 24740,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "When the results were expressed as ED50s, concordance correlation coefficients were well below the defined \u201cgood\u201d cut-off of equal to or greater than 0.8, but when expressed as potencies relative to either 16/284 or 16/322, the concordance correlation coefficients improved (Fig. 4A, D and G).",
            "startOffset": 24447,
            "title": "Agreement between individual laboratories"
        },
        {
            "endOffset": 18153,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Participants are listed in Table 1.",
            "startOffset": 18118,
            "title": "Participants"
        },
        {
            "endOffset": 20441,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Further assessment of agreement in geometric mean potencies for each pair of laboratories was performed by calculating Lin\u2019s concordance correlation coefficient with log transformed potencies relative to IS 16/284 or 16/322.",
            "startOffset": 20217,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27087,
            "parents": [],
            "secId": "s0085",
            "sentence": "Both 16/284 and 16/322 are made up of serum from human adults who are all seropositive for RSV.",
            "startOffset": 26992,
            "title": "Discussion"
        },
        {
            "endOffset": 20817,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The re-calculation could affect the within assay variation for this lab, as the assays may not be optimized to calculate an ED50.",
            "startOffset": 20688,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 23601,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The ability of the BEI Resources human reference antiserum to RSV (NR-4020; sample 6), human antiserum to RSV high control (NR-4021; sample 19) and human reference immunoglobulin to RSV (NR-21973; sample 1) to reduce inter-laboratory variability was also assessed.",
            "startOffset": 23337,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 26608,
            "parents": [],
            "secId": "s0085",
            "sentence": "Palivizumab at 0.1 mg/mL and 1 mg/mL (samples 3 and 14) behaved notably differently from all other samples.",
            "startOffset": 26501,
            "title": "Discussion"
        },
        {
            "endOffset": 23950,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Samples 3 and 14 (palivizumab) were the exception to this with no notable decrease in variability observed.",
            "startOffset": 23843,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 17715,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Human serum samples were collected from volunteers and donated to NIBSC by PATH.",
            "startOffset": 17635,
            "title": "Human serum samples"
        },
        {
            "endOffset": 24130,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Principal component analysis was used to assess the degree of similarity of behaviour between the different sample groups and their results profiles.",
            "startOffset": 23981,
            "title": "Principal component analysis"
        },
        {
            "endOffset": 28685,
            "parents": [],
            "secId": "s0085",
            "sentence": "We were able to successfully show that these samples could reduce inter-laboratory variability of RSV/B neutralisation titres (Table 3) and have proposed IU/mL for these samples (Table 4) based on our proposed assignment of IU to the International Standard (see below).",
            "startOffset": 28416,
            "title": "Discussion"
        },
        {
            "endOffset": 18117,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "11 laboratories agreed to participate with 5 agreeing to perform the assays with and without complement.",
            "startOffset": 18013,
            "title": "Participants"
        },
        {
            "endOffset": 19987,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Any exclusions due to high intra-assay or inter-assay variability within a laboratory are described in the Results section.",
            "startOffset": 19864,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 28280,
            "parents": [],
            "secId": "s0085",
            "sentence": "Further studies where palivizumab is spiked into immunoglobulin depleted serum would be required to test this hypothesis.",
            "startOffset": 28159,
            "title": "Discussion"
        },
        {
            "endOffset": 20909,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "From 11 participants, a total of 16 datasets were received by NIBSC.",
            "startOffset": 20841,
            "title": "Data returned"
        },
        {
            "endOffset": 28158,
            "parents": [],
            "secId": "s0085",
            "sentence": "It has not been tested what effect the other constituents of human serum could have on the neutralising ability of the standard and therefore the importance of the sample matrix for neutralisation analysis is unknown.",
            "startOffset": 27941,
            "title": "Discussion"
        },
        {
            "endOffset": 29692,
            "parents": [],
            "secId": "s0085",
            "sentence": "To that end, we recommend the expansion of the 1st WHO International Standard to RSV to include its use for the measurement of neutralisation titres against RSV/B.",
            "startOffset": 29529,
            "title": "Discussion"
        },
        {
            "endOffset": 21931,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "This led to ~3% of samples being excluded (Fig. 1B).",
            "startOffset": 21879,
            "title": "Intra and Inter-Assay variability"
        },
        {
            "endOffset": 15698,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 15697,
                    "startOffset": 15694
                }
            },
            "secId": "s0005",
            "sentence": "The development of a preventative RSV vaccine is a dynamic field, with at least 38 vaccine candidates in development, with 19 of those in clinical trials [8].",
            "startOffset": 15540,
            "title": "Introduction"
        },
        {
            "endOffset": 22459,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "When the results were categorised by the inclusion or exclusion of complement in the assay, the variability remained high (Fig. 2B and C, and Supplementary Tables 2, 3 and 4).",
            "startOffset": 22284,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 25635,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Concordance correlation coefficients, comparing assays with and without complement, are summarised in Supplementary Table 5 for log10 ED50s and log10 IU (16/284 and 16/322).",
            "startOffset": 25462,
            "title": "Complement effects"
        },
        {
            "endOffset": 26309,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 26308,
                    "startOffset": 26304
                }
            },
            "secId": "s0085",
            "sentence": "This can be explained by the variety of different neutralisation assays available and is consistent with data seen previously of RSV/A neutralisation titres [10].",
            "startOffset": 26147,
            "title": "Discussion"
        },
        {
            "endOffset": 26741,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 26632,
                    "startOffset": 26628
                }
            },
            "secId": "s0085",
            "sentence": "As seen previously [10], both 16/284 and 16/322 were unable to decrease the inter-laboratory variability of the palivizumab samples.",
            "startOffset": 26609,
            "title": "Discussion"
        },
        {
            "endOffset": 15048,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15047,
                    "startOffset": 15044
                }
            },
            "secId": "s0005",
            "sentence": "Respiratory Syncytial Virus (RSV) is a common cause of acute lower respiratory illness leading to hospitalisation and fatalities in children under 5 years of age [1].",
            "startOffset": 14882,
            "title": "Introduction"
        },
        {
            "endOffset": 22832,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "This reduction of %GCV was statistically significant (P < 0.01, F-test of log transformed data).",
            "startOffset": 22736,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 23166,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The same trend was seen when the results were expressed as potencies relative to 16/322 with Max:Min ratios ranging from 2 to 9 and %GCV ranging from 20% to 65%.",
            "startOffset": 23005,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 23337,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "With the palivizumab samples (3 and 14), expressing the results as potencies relative to 16/284 and 16/322 reduced the Max:Min, but there was no notable reduction in %GCV.",
            "startOffset": 23166,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 17940,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The samples were shipped in dry-ice and storage at \u2264\u221220 \u00b0C was recommended.",
            "startOffset": 17865,
            "title": "Sample panel"
        },
        {
            "endOffset": 17613,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The following reagent was obtained through BEI Resources, NIAID, NIH: Panel of Human Antiserum and Immune Globulin to Respiratory Syncytial Virus, NR-32832.",
            "startOffset": 17457,
            "title": "BEI Resources panel"
        },
        {
            "endOffset": 16291,
            "parents": [],
            "secId": "s0005",
            "sentence": "In order to expand the use of this standard to include neutralisation assays against RSV/B, a new collaborative study was conducted.",
            "startOffset": 16159,
            "title": "Introduction"
        },
        {
            "endOffset": 27230,
            "parents": [],
            "secId": "s0085",
            "sentence": "Human serum contains a complex mix of antibodies to multiple RSV proteins that recognise different neutralising and non-neutralising epitopes.",
            "startOffset": 27088,
            "title": "Discussion"
        },
        {
            "endOffset": 20501,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 20500,
                    "startOffset": 20496
                }
            },
            "secId": "s0045",
            "sentence": "These were calculated using the R package \u2018DescTools\u2019 [15].",
            "startOffset": 20442,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 18561,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All participants used their own in-house RSV neutralisation assay and virus stocks.",
            "startOffset": 18478,
            "title": "Participants"
        },
        {
            "endOffset": 21755,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Inter-assay variability was assessed using the ratio of the maximum to minimum (Max:Min) ED50 across all 4 assays performed by each laboratory.",
            "startOffset": 21612,
            "title": "Intra and Inter-Assay variability"
        },
        {
            "endOffset": 19863,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "In some cases, the endpoint ED50 was not covered by the range of dilutions used by the participant and results were reported as \u201cless than\u201d or \u201cgreater than\u201d so all estimates for that sample in that laboratory were excluded from further analysis.",
            "startOffset": 19617,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 26018,
            "parents": [],
            "secId": "s0085",
            "sentence": "In this study we describe the assessment of the 1st WHO International Standard for antiserum to RSV as a suitable candidate reference material to standardise RSV neutralisation assay results against the B subtype of RSV.",
            "startOffset": 25798,
            "title": "Discussion"
        },
        {
            "endOffset": 29528,
            "parents": [],
            "secId": "s0085",
            "sentence": "We have shown that both 16/284 and 16/322 are able to harmonise RSV/B neutralisation data of human serum samples from multiple laboratories.",
            "startOffset": 29388,
            "title": "Discussion"
        },
        {
            "endOffset": 19044,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Assay information, raw data and endpoint readouts were recorded in an Excel spreadsheet provided by the study coordinator.",
            "startOffset": 18922,
            "title": "Study plan"
        },
        {
            "endOffset": 25155,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "When the neutralisation titres were expressed as IU/mL relative to 16/284 and 16/322 this significant difference was lost.",
            "startOffset": 25033,
            "title": "Complement effects"
        },
        {
            "endOffset": 24875,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "This was also true when the data was categorised by the inclusion or exclusion of complement in the assay (Fig. 4B, C, E, F, H and I).",
            "startOffset": 24741,
            "title": "Agreement between individual laboratories"
        },
        {
            "endOffset": 18477,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0050": {
                    "endOffset": 18200,
                    "startOffset": 18196
                }
            },
            "secId": "s0035",
            "sentence": "Compared to the first RSV antiserum study [10], this study contains half the number of laboratory participants, however, this does not affect the validity of the results and is due to fewer laboratories working with the B subtype as routinely as they do with the A subtype and therefore declining to take part in the study.",
            "startOffset": 18154,
            "title": "Participants"
        },
        {
            "endOffset": 19616,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "An F-test was used to calculate the statistical significance of the reduction in %GCV.",
            "startOffset": 19530,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 21108,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "All laboratories submitted datasets from RSV neutralisation assays without guinea pig complement and laboratories 1, 3, 7, 8 and 9 submitted additional datasets including complement in their assays.",
            "startOffset": 20910,
            "title": "Data returned"
        },
        {
            "endOffset": 17033,
            "parents": [],
            "secId": "s0005",
            "sentence": "The BEI Resources panel of human antiserum and immune globulin to RSV (NR-32832) was included in the study panel to allow calibration of these samples, which are currently being used in some laboratories as working standards, against the International Standard.",
            "startOffset": 16772,
            "title": "Introduction"
        },
        {
            "endOffset": 26991,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 26990,
                    "startOffset": 26986
                }
            },
            "secId": "s0085",
            "sentence": "Firstly, palivizumab is a monoclonal antibody that binds to a conserved neutralising epitope on the F (fusion) glycoprotein of RSV [17].",
            "startOffset": 26855,
            "title": "Discussion"
        },
        {
            "endOffset": 21297,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A pair of coded duplicate samples (samples 9 and 15) included in the sample panel was used to assess intra-assay variability and exclude unreliable data.",
            "startOffset": 21144,
            "title": "Intra and Inter-Assay variability"
        },
        {
            "endOffset": 26854,
            "parents": [],
            "secId": "s0085",
            "sentence": "While we have not identified a mechanism for this difference in behaviour, we suggest two possible explanations.",
            "startOffset": 26742,
            "title": "Discussion"
        },
        {
            "endOffset": 24288,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "This technique is an exploratory visual assessment and identified the monoclonal antibody samples as spatially distant from all other sample groups (Fig. 3).",
            "startOffset": 24131,
            "title": "Principal component analysis"
        },
        {
            "endOffset": 19321,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "All ED50s and relative potency estimates were combined as Geometric Means (GM).",
            "startOffset": 19242,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 16015,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 16014,
                    "startOffset": 16011
                }
            },
            "secId": "s0005",
            "sentence": "RSV neutralisation assays vary greatly between laboratories and it is a challenge to accurately compare RSV serum neutralisation titres across multiple formats, laboratories and clinical trials [9].",
            "startOffset": 15817,
            "title": "Introduction"
        },
        {
            "endOffset": 29185,
            "parents": [],
            "secId": "s0085",
            "sentence": "It should be noted that only serum samples from adult humans were tested in this study; the standards may behave differently with paediatric samples.",
            "startOffset": 29036,
            "title": "Discussion"
        },
        {
            "endOffset": 27621,
            "parents": [],
            "secId": "s0085",
            "sentence": "This suggests that 16/284 and 16/322 might also be unsuitable as standards for all other RSV monoclonal antibodies but further studies including other monoclonal antibodies would be required to investigate this.",
            "startOffset": 27410,
            "title": "Discussion"
        },
        {
            "endOffset": 15376,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 15375,
                    "startOffset": 15372
                }
            },
            "secId": "s0005",
            "sentence": "Treatment is limited to supportive care for hospitalised patients and prophylaxis with palivizumab for at risk children and infants [6].",
            "startOffset": 15240,
            "title": "Introduction"
        },
        {
            "endOffset": 26500,
            "parents": [],
            "secId": "s0085",
            "sentence": "Expressing the data relative to 16/284 or 16/322 greatly reduced inter-laboratory variability, showing that the use of standards can make results from different laboratories more comparable.",
            "startOffset": 26310,
            "title": "Discussion"
        },
        {
            "endOffset": 25032,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "When guinea-pig complement was included in the neutralisation assays, significantly increased ED50s were observed (P = 0.0345; Fig. 5A).",
            "startOffset": 24896,
            "title": "Complement effects"
        },
        {
            "endOffset": 18012,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "28 laboratories were invited to participate in the study.",
            "startOffset": 17955,
            "title": "Participants"
        },
        {
            "endOffset": 16771,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this study we aimed to assess the ability of the WHO first International Standard for antiserum to RSV to harmonise RSV/B neutralisation titres and to assess the effect of complement on the effectiveness of the standard.",
            "startOffset": 16548,
            "title": "Introduction"
        },
        {
            "endOffset": 15816,
            "parents": [],
            "secId": "s0005",
            "sentence": "Measuring neutralising activity in serum is a common tool towards assessing the immunogenicity of vaccine candidates.",
            "startOffset": 15699,
            "title": "Introduction"
        },
        {
            "endOffset": 17864,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The sample panel consisted of a total of 20 samples including one duplicate to assess intra-assay variability (Supplementary Table 1).",
            "startOffset": 17730,
            "title": "Sample panel"
        },
        {
            "endOffset": 22113,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The inter-laboratory variability for all samples in all assays (with and without complement) was high when expressed as ED50 (Fig. 2A, Tables 2 and 3).",
            "startOffset": 21962,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 20577,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Laboratory 3 reported their data in a format other than ED50 or equivalent.",
            "startOffset": 20502,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 23004,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Categorising the results by the presence or absence of complement maintained the reduced inter-laboratory variability (Fig. 2E and F, and Supplementary Tables 2, 3 and 4).",
            "startOffset": 22833,
            "title": "Inter-Laboratory variability"
        },
        {
            "endOffset": 20216,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 20215,
                    "startOffset": 20211
                }
            },
            "secId": "s0045",
            "sentence": "An exploratory visual assessment of sample differences was carried out by principal component analysis of potencies relative to 16/284 with the exclusion of laboratory 11 (limited data available) using the ClustVis web tool [14].",
            "startOffset": 19987,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27409,
            "parents": [],
            "secId": "s0085",
            "sentence": "The polyclonal nature of the standards, compared to the monoclonal nature of palivizumab, could explain their inability to harmonise neutralisation titres of palivizumab samples.",
            "startOffset": 27231,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19314951",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "Jacqueline.mcdonald@nibsc.org",
                "first": "Jacqueline U.",
                "initial": "J.U.",
                "last": "McDonald"
            },
            {
                "email": null,
                "first": "Peter",
                "initial": "P.",
                "last": "Rigsby"
            },
            {
                "email": null,
                "first": "Eleanor",
                "initial": "E.",
                "last": "Atkinson"
            },
            {
                "email": "Othmar.Engelhardt@nibsc.org",
                "first": "Othmar G.",
                "initial": "O.G.",
                "last": "Engelhardt"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.10.095",
        "firstpage": "800",
        "issn": "0264410X",
        "keywords": [
            "Collaborative study",
            "Complement",
            "International standard",
            "Neutralisation assay",
            "RSV/B",
            "Respiratory syncytial virus",
            "Standardisation"
        ],
        "lastpage": "807",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study"
    }
}